EV/EBITDA
13.44
+0.01+0.07%
1 min ago
Summary
- As of March 12, 2025, RPRX EV/EBITDA is 13.44, with a rise of +0.01 (+0.07%) during the most recent trading day.
- Over the past year, RPRX EV/EBITDA has increased by +3.14 (+30.49%).
- RPRX EV/EBITDA is now -75.33% below its all-time high of 54.48.
Performance
RPRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RPRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.1% | +0.1% | +0.1% |
| 1 m1 month | +1.0% | +0.9% | +1.4% |
| 3 m3 months | +43.9% | +16.6% | +29.3% |
| 6 m6 months | -12.7% | +11.7% | +14.2% |
| ytdytd | +15.9% | +15.8% | +28.7% |
| 1 y1 year | +30.5% | +7.5% | +6.4% |
| 5 y5 years | - | - | - |
RPRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.3% | 13.23 | +1.6% | |
| 3 m | 3-month | 13.76 | -2.3% | 9.14 | +47.0% |
| 6 m | 6-month | 15.48 | -13.2% | 9.14 | +47.0% |
| 1 y | 1-year | 15.62 | -14.0% | 9.14 | +47.0% |
| 3 y | 3-year | 54.48 | -75.3% | 9.14 | +47.0% |
| 5 y | 5-year | 54.48 | -75.3% | 5.90 | +127.8% |
| alltime | all time | 54.48 | -75.3% | 5.90 | +127.8% |
Royalty Pharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 13.44(+15.9%) |
| 2024 | 11.60(+20.5%) |
| 2023 | 9.63(-82.2%) |
| Date | Value |
|---|---|
| 2022 | 54.07(+239.0%) |
| 2021 | 15.95(+23.8%) |
| 2020 | 12.88 |
FAQ
- What is Royalty Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Royalty Pharma?
- What is RPRX EV/EBITDA year-to-date change?
- What is Royalty Pharma EV/EBITDA year-on-year change?
What is Royalty Pharma EV/EBITDA?
The current EV/EBITDA of RPRX is 13.44
What is the all time high EV/EBITDA for Royalty Pharma?
Royalty Pharma all-time high EV/EBITDA is 54.48
What is RPRX EV/EBITDA year-to-date change?
Royalty Pharma EV/EBITDA has changed by +1.84 (+15.86%) since the beginning of the year
What is Royalty Pharma EV/EBITDA year-on-year change?
Over the past year, RPRX EV/EBITDA has changed by +3.14 (+30.49%)